results from a phase 3 study of 1l atezolizumab vs single-agent chemotherapy in pts with nsclc
Published 1 year ago • 21 plays • Length 5:10Download video MP4
Download video MP3
Similar videos
-
5:36
ipsos: 1l atezolizumab vs single-agent chemotherapy in patients with platinum-ineligible nsclc
-
6:09
impower010: a phase 3 study of atezolizumab vs best supportive care after adjuvant chemotherapy ...
-
2:30
#esmo22 highlights on first-line atezolizumab in nsclc not eligible for platinum: the ipsos study
-
1:49
phase 3 trials of atezolizumab versus standard chemotherapy in pd-l1-selected nsclc
-
5:18
atezolizumab improves on single-agent chemo for nsclc not eligible for platinum-containing regimen
-
6:20
atezolizumab for locally advanced or metastatic pd-l1-selected nsclc
-
4:18
impower110: atezolizumab vs chemo in pd-l1–selected nsclc
-
5:05
anti–pd-l1 atezolizumab or chemotherapy as second-line therapy in patients with sclc
-
3:27
#esmo21 highlights on patterns of relapse in nsclc to atezolizumab vs bsc after adj ct: impower010
-
4:55
atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma
-
5:32
esmo22 - lba11 ipsos - results 1st-line atezolizumab vs single-agent ct in nsclc not eligible f...
-
4:31
impower130: pfs and safety of adding atezolizumab to first-line nsclc therapy
-
6:06
atezolizumab monotherapy vs docetaxel in 2nd and 3rd line nsclc
-
0:42
beat-sc: phase iii trial of bevacizumab or placebo with atezolizumab & chemo in extensive-stage sclc
-
2:20
selecting patients with nsclc who benefit from immunotherapy or targeted therapies
-
3:17
impower010: os results of atezolizumab vs best supportive care in resected nsclc
-
9:24
impower010 supports adjuvant atezolizumab in early-stage nsclc | heather wakelee
-
1:12
dr. horn discusses next steps with atezolizumab in sclc
-
2:18
final os results of imvigor130: 1l atezolizumab /- chemotherapy in metastatic urothelial carcinoma